• Blog

Five Key Trends Impacting Hospitals in 2025

Image

Dr Paul Chidester, MD, FACP

Chief Medical Officer

As we navigate the evolving landscape of healthcare in 2025, I’m witnessing key trends that are shaping inpatient care.

These shifts, fueled by advancements in technology, changing patient expectations, and workforce challenges, underscore the increasing importance of clinical decision support (CDS) and technology in improving care delivery.

Here are the top five trends that stand out to me:

1. Addressing Workforce Challenges

Healthcare workforce shortages continue to impact hospitals, with the AHA projecting a significant nursing shortfall by 2030.

Hospitals are responding with flexible scheduling, training programs, and technology solutions to support their teams through decreased cognitive burden while maintaining care standards.

CDS tools like EndoTool ease nursing burden, allowing increased times between glucose checks and reducing overall bedside task workload for nurses.

2. The Continued Shift to Value-Based Care

Value-based care models are gaining ground, emphasizing patient outcomes over the volume of services. With a 20% increase in hospital participation in value-based payment programs, data analytics tools are helping hospitals track outcomes, reduce readmissions, and lower costs.

Based on a 2024 change, CMS is gearing up to introduce updates to value-based metrics reporting, aiming to streamline data collection and focus on measures that more accurately reflect patient care quality.

3. AI-Enhanced Clinical Decision Support

Artificial intelligence is becoming essential in inpatient care, improving staff efficiency and personalizing treatments.

AI-driven algorithms can analyze lab results to identify early warning signs of critical conditions, enabling timely interventions that can save lives.

In insulin management, clinical decision support tools like EndoTool, which use machine learning to continually adapt to patient response are crucial in preventing severe glucose fluctuations providing a recommended dose of insulin resulting in improved care and a reduction in clinician workload.

4. Adoption of Remote Monitoring in Inpatient Settings

Technologies like wearable devices and sensors, once limited to outpatient care, are now widely used in inpatient settings.

Continuous Glucose Monitors (CGMs) have become essential, providing real-time glucose updates that help clinicians enhance precision by detecting trends, preventing glucose-related events, and reducing the need for frequent blood draws thus improving patient comfort.

Integrated into remote monitoring systems, CGMs allow clinicians to manage multiple patients efficiently, boosting care quality and addressing workforce shortages.

5. Focus on Interoperability

Interoperability remains a priority as healthcare organizations work to improve data exchange between electronic health records (EHRs), medical devices, and analytics platforms.

By ensuring seamless data sharing, hospitals can enhance care coordination and reduce errors caused by disconnected systems.

Integrated CDS tools like EndoTool further support clinicians by ensuring that they have access to accurate information seamlessly.

Conclusion

These trends underscore our collective commitment to advancing patient care while addressing systemic challenges.

They guide our strategic roadmap, helping us prioritize investments and operational enhancements that align with our mission of delivering high-quality, efficient care in insulin management.

Leveraging these insights, we position our organization to meet the demands of 2025 and beyond with innovation and resilience.

About EndoTool

Made by Monarch Medical Technologies, EndoTool is the only patient-specific insulin dosing system which simplifies the complex task of glycemic management in hospital environments. The recommended dosing is different for each patient based on multiple clinical characteristics. The FDA-cleared platform is utilized in hundreds of hospitals across the United States and is fully integrated with all major electronic medical records. To see how EndoTool can support your health system, get in touch today.

About the author

Dr Paul Chidester, MD, FACP | Chief Medical Officer

Dr. Paul Chidester is the Chief Medical Officer for Monarch Medical Technologies. After practicing for two decades as a nephrologist, he assumed a senior leadership role at Sentara Healthcare where he led the implementation of computerized insulin dosing software. He is involved with product development and customer engagement at Monarch Medical Technologies where the focus is to provide precision insulin dosing for patients. His key interest is working to further enhance this precision through the use of technologies such as CGM.

Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.